A medication used primarily to help relieve the side effects of chemotherapy has been given the green light to be used as a treatment for a rare neurological disorder. However, the FDA announcement ...
Corrections and clarifications: Due to an editing error, a previous version of this story mischaracterized the scope of the new FDA approval for leucovorin. The Food and Drug Administration has denied ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results